Clinical Mass Spectrometry Market Analysis
Clinical Mass Spectrometry Market, by Application (Proteomics, Drug discovery, and Clinical Testing), by Product Type (Liquid chromatography–mass spectrometry (LC- MS) instrument, Gas chromatography–mass spectrometry (GC-MS) instrument , MALDI-TOF mass spectrometer, Ion mobility spectrometry-mass spectrometry, and Capillary electrophoresis–mass spectrometry), by Region (Africa, Latin America, Asia Pacific, the Middle East, Europe, and North America), and by End User (Hospitals, Diagnostic Laboratories, and Research Laboratories) – Size, Outlook, Share, and Opportunity Analysis, 2019–2027
The application of clinical mass spectrometry has gained widespread acceptance in specialized clinical labs and research settings, and its implementation in routine labs is experiencing a significant increase. This technology has seen significant growth due to its combination with liquid chromatography (LC) or gas chromatography (GC). The clinical utility of mass spectrometry (MS) extends to various fields, including drugs of abuse, clinical toxicology, and therapeutic drug monitoring.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/193
Clinical mass spectrometry is a versatile analytical technique that can both quantify and qualify complex mixtures, making it valuable throughout all stages of drug development, including identifying lead compounds and their structural descriptions. Clinical labs handle a vast amount of samples utilizing either analyzer automation or total automation that is facilitated by clinical mass spectrometers like matrix-assisted laser desorption/ionization (MALDI-TOF). Clinical laboratories, being one of the primary consumers in this market, benefit greatly from the assistance of automated platforms that facilitate the efficient processing of ever-growing workloads.
The progress made in clinical mass spectrometry has made it easier to measure and differentiate the individual contributions of various molecules, like thyroid hormones, as well as 25-hydroxyl vitamins D3 and D2. Translational research in mass spectrometry has been applied to identify new disease biomarkers, endogenous metabolites, blood-based biomarkers, and tumor markers. As a result, these progressions are likely to drive the need for clinical mass spectrometry devices.
According to estimates in 2019, the global clinical mass spectrometry market was worth US$ 697.2 Mn and it is projected to grow at a CAGR of 5.5% from 2019 to 2027.
The clinical mass spectrometry market is anticipated to experience growth driven by the rising need for automation in diagnostic techniques.
The utilization of mass spectrometry is advantageous for various purposes, including functional genomics, proteomics, and metabolomics research and diagnostic analysis. This has resulted in an increased demand for an affordable sample analysis platform, prompting manufacturers to concentrate on product development and advancements to meet the requirement for automated diagnostic tools. In 2017, Thermo Fisher Scientific Inc. introduced the Scientific Cascadion SM Clinical Analyzer during a EuroMedLab event in Athens, Greece, which employs clinical analyzers with the sensitivity and specificity of liquid chromatography-tandem mass spectrometry.
Automated laboratory systems offer advanced capabilities like Mass EXTEND primer extension and the dispensing of samples in nanoliter quantities onto spectroCHIPS. These systems utilize pre-loaded workstations for data analysis, making them easy to manage and delivering fast results with simple operation–all at a lower cost. In addition to being cost-effective, mass spectrometers offer several benefits over conventional immunoassays, including enhanced quality assays, automation, ease of use, heightened sensitivity, reliable data output, non-specific binding, and reduced cross-reactivity, and minimal downtime.
The global market growth is anticipated to be hindered by the capital investment required for installing and maintaining the devices. Mass spectrometers are beyond the financial reach of small diagnostic laboratories and clinics, particularly in developing nations. Furthermore, operating the devices requires a skilled workforce and is labor-intensive. The lack of skilled operators is predicted to impede the market’s growth.
The global clinical mass spectrometry market is categorized into Africa, Latin America, Asia Pacific, the Middle East, Europe, and North America based on geographical regions.
The clinical mass spectrometry market in North America is predicted to have the highest market share during the projected timeframe due to factors such as research and development initiatives, as well as substantial government support, which are driving the market’s growth in the region. For example, the Federation of Analytical Chemistry and Spectrometry Societies and the American Society for Mass Spectrometry were established in 1969, with over 7,500 scientists collaborating to advance the clinical application of mass spectrometry and related topics in the industrial, academic, and government sectors. As a result, a robust research foundation has been established in North America, prompting to the region’s clinical mass spectrometry market growth.
Prominent players, including Mass Spectrometry Instruments (MSI), Bruker Corporation, Danaher Corporations, Bergman Messgerate Entwicklung KG, Thermo Fisher Scientific Inc., Kore Technology Limited, and Agilent Technologies, are operating in the global clinical mass spectrometry market.
We Offer Customized Report, Click @ https://www.coherentmarketinsights.com/insight/request-customization/193
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Clinical Mass Spectrometry Market Size Analysis from 2023 to 2030
11.6 COVID-19 Outbreak: Clinical Mass Spectrometry Industry Impact
Chapter 2 Global Clinical Mass Spectrometry Competition by Types, Applications, and Top Regions and Countries
2.1 Global Clinical Mass Spectrometry (Volume and Value) by Type
2.3 Global Clinical Mass Spectrometry (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Clinical Mass Spectrometry Sales, Consumption, Export, Import by Regions (2017-2023)
Chapter 5 North America Clinical Mass Spectrometry Market Analysis
Chapter 6 East Asia Clinical Mass Spectrometry Market Analysis
Chapter 7 Europe Clinical Mass Spectrometry Market Analysis
Chapter 8 South Asia Clinical Mass Spectrometry Market Analysis
Chapter 9 Southeast Asia Clinical Mass Spectrometry Market Analysis
Chapter 10 Middle East Clinical Mass Spectrometry Market Analysis
Chapter 11 Africa Clinical Mass Spectrometry Market Analysis
Chapter 12 Oceania Clinical Mass Spectrometry Market Analysis
Chapter 13 South America Clinical Mass Spectrometry Market Analysis
Chapter 14 Company Profiles and Key Figures in Clinical Mass Spectrometry Business
Chapter 15 Global Clinical Mass Spectrometry Market Forecast (2023-2030)
Chapter 16 Conclusions
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/193
Explore More Related Insights:
Platelet aggregation devices market
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400,
Burlingame, CA 94010, United States
Phone: US +12067016702 / UK +4402081334027